TABLET TOSCANA to Develop Innovative Organizational Models for Tele-Rehabilitation in Subjects with Congenital and Acquired Developmental Disabilities: A Wait-List Control Group Trial Protocol.

TABLET TOSCANA to Develop Innovative Organizational Models for Tele-Rehabilitation in Subjects with Congenital and Acquired Developmental Disabilities: A Wait-List Control Group Trial Protocol.

Publication date: Jul 16, 2024

Background/Objectives: In recent years, the advent of new technologies has fostered their application in neuro-psychomotor and language rehabilitation, particularly since the COVID-19 pandemic. Tele-rehabilitation has emerged as an innovative and timely solution, enabling personalized interventions monitored by clinicians. TABLET TOSCANA project aims to develop innovative tele-rehabilitation organizational models in children, adolescents and young adults with congenital and acquired developmental disabilities, using the Virtual Reality Rehabilitation System (VRRS) Home Kit and the MedicoAmico APP. Methods: The trial is designed according to the CONSORT statement guidelines. The project encompasses three phases: adapting the technologies for pediatric use, validating them through a wait-list study, and analyzing feasibility and effectiveness data to define new organizational models. A randomized wait-list-control study with 100 subjects aged 6 to 30 years will compare tele-rehabilitation versus prosecution of standard care. Discussion: Although literature highlights tele-rehabilitation benefits such as improved access, cost savings, and enhanced treatment adherence, practical implementation remains limited (i. e., the definition of standardized procedures). TABLET TOSCANA project seeks to address these gaps by focusing on multi-domain treatments for neurodevelopmental disabilities and emphasizing the integration of tele-rehabilitation into local health services. Conclusion: The project aims to improve the continuity and intensity of care through innovative models that integrate tele-rehabilitation into local health services. The results could inform healthcare policies and promote the development of innovative and collaborative models of care, paving the way for more effective and widespread tele-rehabilitation solutions and fostering collaborative networks among professionals.

Open Access PDF

Concepts Keywords
Advent COVID-19
Healthcare feasibility
Models neurodevelopmental disorders
Neurodevelopmental organizational models
Pandemic pediatric neurological rehabilitation
tele-rehabilitation

Semantics

Type Source Name
disease MESH Developmental Disabilities
disease VO protocol
disease VO Advent
disease MESH COVID-19 pandemic
disease VO effectiveness
disease VO effective
disease MESH neurodevelopmental disorders
drug DRUGBANK Coenzyme M
disease MESH emergency
disease IDO intervention
drug DRUGBANK Trestolone
disease VO frequency
disease VO population
disease MESH neurological disorders
disease VO device
drug DRUGBANK Tretamine
disease IDO process
drug DRUGBANK Fenamole
disease MESH visual impairments
drug DRUGBANK Etoperidone
drug DRUGBANK Isoxaflutole
drug DRUGBANK Dimercaprol
disease VO time
disease MESH facial expressions
disease IDO hospital facility
drug DRUGBANK BIA
drug DRUGBANK Acetohydroxamic acid
disease MESH Movement disorders
drug DRUGBANK L-Valine
disease VO ANOVA

Original Article

(Visited 1 times, 1 visits today)